G01N 2333/70507
C2d
G01N2333/70507 (C2d) appears on 23 US grants and 33 published applications in this corpus.
Search patents in G01N- Granted patents
- 23
- Published applications
- 33
- Assignees
- 17
- Inventors
- 41
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 2 |
| 2003 | 0 | 0 |
| 2004 | 1 | 2 |
| 2005 | 1 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 4 |
| 2009 | 0 | 2 |
| 2010 | 6 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 2 | 2 |
| 2019 | 1 | 2 |
| 2020 | 2 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 2 |
| 2025 | 0 | 1 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- African swine fever DIVA immunoassay18 Aug 2026US 12,710,423 B2Intervet Inc.
- Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer21 Apr 2026US 12,606,621 B2Precision Biologics, Inc.
- Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions1 Oct 2024US 12,103,958 B2Pfizer Inc.
- Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer22 Nov 2022US 11,505,604 B2Precision Biologics, Inc.
- Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer23 Jun 2020US 10,689,443 B2Precision Biologics, Inc.
- Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer17 Sep 2026US 2026/0274947 A1Precision Biologics, Inc.
- Lfa3 variants and compositions and uses thereof22 May 2025US 2025/0163125 A1Pfizer Inc.
- Method of diagnosing and treating nonalcoholic fatty liver disease and nonalcoholic steatohepatitis7 Mar 2024US 2024/0077498 A1Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- African swine fever diva immunoassay15 Feb 2024US 2024/0053340 A1Intervet Inc.
- Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer21 Sep 2023US 2023/0295298 A1Precision Biologics, Inc.
Most cited
By later US patents
- Method of analyzing lymphocytes17US 7,816,135 B2Becton, Dickinson and Company · 2010
- Assays for preimplantation factor and preimplantation factor peptides14US 7,273,708 B2Bioincept, LLC · 2007
- Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction14US 7,323,171 B2Astellas US LLC · 2008
- Diagnostics assay methods and amelioration of muscular dystrophy symptoms10US 6,858,395 B2The Board of Trustees of the University of Illinois · 2005
- Assays for preimplantation factor and preimplantation factor peptides9US 7,670,850 B2Bioincept, LLC · 2010